<DOC>
	<DOCNO>NCT00772720</DOCNO>
	<brief_summary>Raltegravir first new antiretroviral class . A good profile metabolic toxicity expect . In order well define effect , without interference drug , study healthy volunteer warrant .</brief_summary>
	<brief_title>Effects Raltegravir ( IsentressÂ® ) Lipid Carbohydrate Metabolism Mitochondrial Function Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>1 . Healthy male . 2. age 18 45 . 3 . BMI 19 25 kg/m2 4 . Normal physical exam . 5 . Blood analysis without relevant finding . 6 . Negative serology hepatitis B , Hepatitis C HIV . 7 . Negative urine test abuse drug . 1 . Severe psychiatric disease . 2 . Dyslipemia . 3 . Alcohol intake 30 g per day . 4 . Smokers 5 . Xanthine intake 5 coffee cup equivalent per day 6 . Use drug last month 7 . Participation trial last 3 month 8 . Diseases capable modify drug ADME 9 . Drug allergy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>